Verenigde Staten - Engels - NLM (National Library of Medicine)

wyeth pharmaceuticals inc., a subsidiary of pfizer inc. - piperacillin sodium (unii: m98t69q7hp) (piperacillin anhydrous - unii:9i628532gx), tazobactam sodium (unii: uxa545abtt) (tazobactam - unii:se10g96m8w) - piperacillin anhydrous 2 g in 50 ml - zosyn is indicated for the treatment of patients with moderate to severe infections caused by piperacillin-resistant, piperacillin/tazobactam-susceptible, β-lactamase producing strains of the designated microorganisms in the specified conditions listed below: appendicitis (complicated by rupture or abscess) and peritonitis caused by piperacillin-resistant, β‑lactamase producing strains of escherichia coli or the following members of the bacteroides fragilis group: b. fragilis , b. ovatus , b. thetaiotaomicron , or b. vulgatus . the individual members of this group were studied in less than 10 cases. uncomplicated and complicated skin and skin structure infections, including cellulitis, cutaneous abscesses, and ischemic/diabetic foot infections caused by piperacillin-resistant, β‑lactamase producing strains of staphylococcus aureus . postpartum endometritis or pelvic inflammatory disease caused by piperacillin-resistant, β‑lactamase producing strains of escherichia coli . community-acquired pneumonia (modera

Verenigde Staten - Engels - NLM (National Library of Medicine)

mitim s.r.l. - piperacillin sodium (unii: m98t69q7hp) (piperacillin anhydrous - unii:9i628532gx), tazobactam sodium (unii: uxa545abtt) (tazobactam - unii:se10g96m8w) - piperacillin anhydrous 2 g in 10 ml - piperacillin and tazobactam for injection, usp is a combination product consisting of a penicillin-class antibacterial, piperacillin, and a β-lactamase inhibitor, tazobactam, indicated for the treatment of patients with moderate to severe infections caused by susceptible isolates of the designated bacteria in the conditions listed below. appendicitis (complicated by rupture or abscess) and peritonitis caused by β-lactamase producing isolates of escherichia coli or the following members of the bacteroides fragilis group: b. fragilis , b. ovatus , b. thetaiotaomicron , or b. vulgatus . the individual members of this group were studied in fewer than 10 cases. uncomplicated and complicated skin and skin structure infections, including cellulitis, cutaneous abscesses and ischemic/diabetic foot infections caused by β-lactamase producing isolates of staphylococcus aureus . postpartum endometritis or pelvic inflammatory disease caused by β-lactamase producing isolates of escherichia coli . community-acquired pneumo

Australië - Engels - Department of Health (Therapeutic Goods Administration)

pharmaco australia ltd - ganciclovir sodium, quantity: 543 mg (equivalent: ganciclovir, qty 500 mg) - injection, powder for - excipient ingredients: - indications as at 12 october 2005: cymevene (ganciclovir) administered as the intravenous infusion is indicated for the palliative treatment of confirmed sight-threatening cytomegalovirus (cmv) disease in aids and other severely immunocompromised individuals. it is indicated for the treatment of confirmed cmv pneumonitis in bone marrow transplant patients. it is also indicated for the prophylaxis of cmv infection and disease following bone marrow and solid organ transplantation in patients at risk of cmv disease. note: cymevene (ganciclovir) is not indicated for congenital or neonatal cmv disease; nor for the treatment of cmv infection in non-immunocompromised individuals.

Bahrein - Engels - الهيئة الوطنية لتنظيم المهن والخدمات الصحية، مملكة البحرين

gulf pharmacy - cilastatin sodium, imipenem - powder for soln.for infusion - 500

Bahrein - Engels - الهيئة الوطنية لتنظيم المهن والخدمات الصحية، مملكة البحرين

gulf pharmacy - cilastatin sodium, imipenem - powder for soln. for injection - 500

Verenigd Koninkrijk - Engels - MHRA (Medicines & Healthcare Products Regulatory Agency)

organon pharma (uk) ltd - cilastatin sodium; imipenem monohydrate - powder for suspension for injection - 500mg ; 500mg

Maleisië - Engels - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

ranbaxy (malaysia) sdn. bhd. - cilastatin sodium; imipenem -

Zimbabwe - Engels - Medicines Control Authority

sun pharmaceutical industries limited - cilastatin sodium; imipenem - powder/injectable; injection - 500; 500 mg

Verenigde Arabische Emiraten - Engels - MOHAP (Ministry of Health & Prevention) - وزارة الصحة ووقاية المجتمع.الإمارات

cilastatin sodium 571mg equivalent to cilastin , imipenem monohydrate 560mg equivalent to imipenem anhydrous -

Australië - Engels - Department of Health (Therapeutic Goods Administration)

cilastatin; imipenem -